European Neuropsychopharmacology

SJR Rank #1,082H-index: 139SJR: 2.334Best quartile: Q1APC: US$3,000
Journal website: aims, scope and author guidelines
Publisher

Elsevier B.V.

Country

Netherlands

Type

journal

SJR by Edition

2022202500.61.21.82.4

Subject Categories

  • Biological PsychiatryQ1
  • NeurologyQ1
  • Neurology (clinical)Q1
  • PharmacologyQ1
  • Pharmacology (medical)Q1
  • Psychiatry and Mental HealthQ1

Areas: Medicine · Neuroscience · Pharmacology, Toxicology and Pharmaceutics

Most published research topics

Schizophrenia research and treatmentTreatment of Major DepressionBipolar Disorder and TreatmentTryptophan and brain disordersNeurotransmitter Receptor Influence on BehaviorNeuroscience and Neuropharmacology ResearchStress Responses and CortisolAttention Deficit Hyperactivity DisorderFunctional Brain Connectivity StudiesReceptor Mechanisms and Signaling

Source: OpenAlex

Publication Statistics

2025 Docs3-Year DocsCitable Docs0150300450600

Documents per Year

2022202504080120160

Detailed Information

ISSN

0924-977X, 1873-7862

SJR Best Quartile

Q1

Region

Western Europe

Citations per Document (2 years)

4.83

References per Document

28.99

Coverage

1990-2026

Scope

European Neuropsychopharmacology is the official publication of the European College of Neuropsychopharmacology (ECNP). In accordance with the mission of the College, the journal focuses on clinical and basic science contributions that advance our understanding of brain function and human behaviour and enable translation into improved treatments and enhanced public health impact in psychiatry. Recent years have been characterized by exciting advances in basic knowledge and available experimental techniques in neuroscience and genomics. However, clinical translation of these findings has not been as rapid. The journal aims to narrow this gap by promoting findings that are expected to have a major impact on both our understanding of the biological bases of mental disorders and the development and improvement of treatments, ideally paving the way for prevention and recovery.

Metrics from SCImago Journal Rank 2025. View on SCImago